These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 21178437)
21. Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load. De Wit S; Delforge M; Necsoi CV; Clumeck N AIDS; 2011 Jun; 25(10):1332-3. PubMed ID: 21508802 [TBL] [Abstract][Full Text] [Related]
22. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease. Santin M; Mestre M; Shaw E; Barbera MJ; Casanova A; Niubo J; Bolao F; Podzamczer D; Gudiol F Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):65-73. PubMed ID: 17938979 [TBL] [Abstract][Full Text] [Related]
24. CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. Kovacs A; Al-Harthi L; Christensen S; Mack W; Cohen M; Landay A J Infect Dis; 2008 May; 197(10):1402-7. PubMed ID: 18444798 [TBL] [Abstract][Full Text] [Related]
25. [Adaptive cell immune response against the hepatitis C virus infection]. Rallón NI; Soriano V; Benito JM Med Clin (Barc); 2007 Oct; 129(12):469-76. PubMed ID: 17953913 [TBL] [Abstract][Full Text] [Related]
26. CD8+/CD38+: immune activity and clinical significance in HCV patients with and without interferon therapy. Perrella A; Perrella ; Conca P; Tarantino G Eur Rev Med Pharmacol Sci; 2000; 4(5-6):127-31. PubMed ID: 11710510 [TBL] [Abstract][Full Text] [Related]
27. Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment. Rempel H; Sun B; Calosing C; Abadjian L; Monto A; Pulliam L PLoS One; 2013; 8(2):e55776. PubMed ID: 23437063 [TBL] [Abstract][Full Text] [Related]
28. Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection. Portales P; Reynes J; Rouzier-Panis R; Baillat V; Clot J; Corbeau P AIDS; 2003 Mar; 17(4):505-11. PubMed ID: 12598770 [TBL] [Abstract][Full Text] [Related]
29. [Interactions between the human immunodeficiency virus and hepatitis C virus]. Pol S; Zylberberg H Rev Med Interne; 1998 Dec; 19(12):885-91. PubMed ID: 9887456 [TBL] [Abstract][Full Text] [Related]
30. Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). Shata MT; Abdel-Hameed EA; Hetta HF; Sherman KE J Clin Pathol; 2013 Nov; 66(11):967-75. PubMed ID: 23940131 [TBL] [Abstract][Full Text] [Related]
31. Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. Hardy GA; Sieg S; Rodriguez B; Anthony D; Asaad R; Jiang W; Mudd J; Schacker T; Funderburg NT; Pilch-Cooper HA; Debernardo R; Rabin RL; Lederman MM; Harding CV PLoS One; 2013; 8(2):e56527. PubMed ID: 23437155 [TBL] [Abstract][Full Text] [Related]
32. Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. Falconer K; Gonzalez VD; Reichard O; Sandberg JK; Alaeus A J Clin Virol; 2008 Feb; 41(2):160-3. PubMed ID: 18093872 [TBL] [Abstract][Full Text] [Related]
33. Reciprocal influence of HIV and HCV infections in co-infected patients and the involvement of HAART. Tamalet C; Colson P Clin Microbiol Infect; 2003 Mar; 9(3):159-60. PubMed ID: 12667247 [TBL] [Abstract][Full Text] [Related]
34. Coinfection with HIV-1 and HCV--a one-two punch. Kim AY; Chung RT Gastroenterology; 2009 Sep; 137(3):795-814. PubMed ID: 19549523 [TBL] [Abstract][Full Text] [Related]
35. Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy. Hengst J; Strunz B; Deterding K; Ljunggren HG; Leeansyah E; Manns MP; Cornberg M; Sandberg JK; Wedemeyer H; Björkström NK Eur J Immunol; 2016 Sep; 46(9):2204-10. PubMed ID: 27296288 [TBL] [Abstract][Full Text] [Related]
36. HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation. Silverstein PS; Kumar S; Kumar A Curr HIV Res; 2014; 12(4):282-92. PubMed ID: 25053363 [TBL] [Abstract][Full Text] [Related]
37. [Human immunodeficiency virus/hepatitis C virus co-infection: do we have the right not to treat our patients?]. Locutura J; Francisco Lorenzo J; Miján A Enferm Infecc Microbiol Clin; 2001; 19(6):286. PubMed ID: 11440676 [No Abstract] [Full Text] [Related]
38. Evolutionary dynamics of Hepatitis C virus in a chronic HIV co-infected patient and its correlation with the immune status. Culasso ACA; Monzani MC; Baré P; Campos RH Infect Genet Evol; 2018 Sep; 63():30-38. PubMed ID: 29733983 [TBL] [Abstract][Full Text] [Related]
39. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. Zhen A; Rezek V; Youn C; Lam B; Chang N; Rick J; Carrillo M; Martin H; Kasparian S; Syed P; Rice N; Brooks DG; Kitchen SG J Clin Invest; 2017 Jan; 127(1):260-268. PubMed ID: 27941243 [TBL] [Abstract][Full Text] [Related]
40. [Humoral response to hepatitis C virus antigens in coinfection with human immunodeficiency virus type 1]. Nikolaeva LI; Zverev SIa; Petrova EV; Samokhvalov EI; Al'khovskiĭ SV; Tokmalaev AK; Kazennova EV; Bobkova MR Klin Lab Diagn; 2008 Jul; (7):42-4. PubMed ID: 18756735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]